Psoriasis patient and advocate Diane Talbert is one of several speaking out about her experiences in a new initiative from Bristol Myers Squibb (via Bristol Myers website)
November 6, 2023 03:20 PM EST
Pharma
Marketing

Bris­tol My­er­s' new ef­fort spot­lights pso­ri­a­sis pa­tients and physi­cians from around the world

Beth Snyder Bulik

Senior Editor

Bris­tol My­ers Squibb is go­ing glob­al to chron­i­cle the re­al world pso­ri­a­sis ex­pe­ri­ences of physi­cians and pa­tients, specif­i­cal­ly high­light­ing the chal­lenges for peo­ple of col­or …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times